Range Low Price High Price Comment
30 days $1.71 $3.40 Tuesday, 30th Apr 2024 ESPR stock ended at $1.97. This is 1.01% less than the trading day before Monday, 29th Apr 2024. During the day the stock fluctuated 4.90% from a day low at $1.94 to a day high of $2.04.
90 days $1.71 $3.40
52 weeks $0.700 $3.40

Historical Esperion Therapeutics prices

Date Open High Low Close Volume
Mar 09, 2016 $15.83 $16.23 $15.31 $15.72 414 200
Mar 08, 2016 $18.06 $18.15 $15.55 $15.80 542 100
Mar 07, 2016 $17.28 $18.76 $16.69 $18.32 644 800
Mar 04, 2016 $17.53 $18.45 $17.10 $17.32 550 200
Mar 03, 2016 $18.21 $18.44 $17.10 $17.33 677 300
Mar 02, 2016 $15.72 $18.37 $15.59 $18.25 912 700
Mar 01, 2016 $15.20 $15.64 $14.84 $15.53 572 100
Feb 29, 2016 $15.45 $15.65 $14.37 $14.89 574 600
Feb 26, 2016 $15.10 $15.80 $14.83 $15.54 483 700
Feb 25, 2016 $15.96 $16.46 $14.91 $14.97 485 500
Feb 24, 2016 $15.34 $16.21 $14.35 $16.09 601 300
Feb 23, 2016 $16.60 $16.96 $15.71 $15.74 431 400
Feb 22, 2016 $16.50 $17.34 $16.25 $16.93 382 100
Feb 19, 2016 $15.85 $16.92 $15.51 $16.58 367 700
Feb 18, 2016 $16.72 $16.72 $15.46 $15.97 394 900
Feb 17, 2016 $16.26 $16.88 $16.06 $16.68 566 600
Feb 16, 2016 $15.11 $16.18 $15.11 $16.03 353 400
Feb 12, 2016 $14.75 $15.00 $13.85 $14.92 300 400
Feb 11, 2016 $13.56 $14.92 $13.28 $14.60 413 200
Feb 10, 2016 $14.40 $15.70 $14.00 $14.06 335 300
Feb 09, 2016 $13.62 $14.95 $13.46 $14.31 463 300
Feb 08, 2016 $15.07 $15.27 $13.65 $14.10 500 600
Feb 05, 2016 $15.90 $16.49 $15.00 $15.54 595 200
Feb 04, 2016 $14.92 $16.45 $14.44 $16.15 602 900
Feb 03, 2016 $14.93 $15.38 $13.45 $15.28 568 600
Click to get the best stock tips daily for free!

About Esperion Therapeutics

Esperion Therapeutics Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration a... ESPR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT